Clinical Trial Update: A Trial to Evaluate the Frequency of Genetic Sucrase-Isomaltase Deficiency Genotypes, and the Efficacy and Safety of Sucraid® (Sacrosidase) Oral Solution in Subjects With Chronic Diarrhea and Sucrase Deficiency [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating sucrase-isomaltase deficiency with Sacrosidase was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Genetic Sucrase-isomaltase Deficiency

Drugs mentioned

• SUCRAID (sacrosidase)

Snippet

Sponsor: QOL Medical, LLC | Conditions: Genetic Sucrase-Isomaltase Deficiency | Phase 4 | Status: WITHDRAWN